OPKO Health Unit to Expand Pro-Sports Covid Testing to NFL

OPKO Health Inc. soared to its highest intraday level in more than 2 1/2 years after its BioReference Laboratories unit said it will provide Covid-19 tests to the National Football League this year.

Jon Cohen, BioReference’s executive chairman, said on CNBC’s “Mad Money” program that the tests would be administered to all 32 teams. Opko, in a brief filing, said the unit had reached an agreement in principle with the league.

The agreement expands BioReference’s footprint in the pro-sports world. Earlier this month, it said it has agreements to provide testing to the National Basketball Association and ...